InspireMD Sees 33% Revenue Increase Fuelled By MGuard™ Embolic Protection Stent

InspireMD Reports Financial Results For Period Ended March 31, 2013 (via PR Newswire)

– Revenue increased 33% over prior year – – Several key milestones achieved – BOSTON and TEL AVIV, Israel, May 8, 2013 /PRNewswire/ — InspireMD, Inc. (“InspireMD” or the “Company”) (NYSE MKT: NSPR), a leader in embolic protection stents, today announced financial results for the three month period…